Molnupiravir
- 7. included 302 patients who were randomly assigned 1:1:1:1 to receive
molnupiravir 200mg, 400mg, 800mg, or placebo twice daily for 5 days.
- 9. • Merck will receive $1.2 billion to supply 1.7 million courses of molnupiravir to the
United States government.